News on Ophidia Products%2C Inc. from BioPortfolio.com http://www.BioPortfolio.com Consolidated Ophidia Products%2C Inc. news from BioPortfolio.com Wed, 10 Feb 2010 10:45:24 GMT en Airgas board rejects Air Products' buyout offerhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039272&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ophidia%20Products,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039272&THISHREF=http://c.moreover.com/click/here.pl%3fz2537992724%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039272&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ophidia%20Products,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039272&THISHREF=http://c.moreover.com/click/here.pl%3fz2537992724%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comResearch & Development: Business news in briefhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040236&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ophidia%20Products,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040236&THISHREF=http://c.moreover.com/click/here.pl%3fz2538669738%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040236&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ophidia%20Products,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040236&THISHREF=http://c.moreover.com/click/here.pl%3fz2538669738%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPhiladelphia Inquirer: BiomedReports: News and FDA Updates for PPD (Nasdaq:PPDI), Repros Therapeutics (Nasdaq:RPRX), Stem Cell Theraphttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039165&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ophidia%20Products,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039165&THISHREF=http://c.moreover.com/click/here.pl%3fz2537964625%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039165&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ophidia%20Products,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039165&THISHREF=http://c.moreover.com/click/here.pl%3fz2537964625%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comQuote.com Japan: Agrium Inc. Q4 2009 Earnings Call Transcripthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038898&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ophidia%20Products,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038898&THISHREF=http://c.moreover.com/click/here.pl%3fz2537827455%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038898&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ophidia%20Products,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038898&THISHREF=http://c.moreover.com/click/here.pl%3fz2537827455%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSeeking Alpha: AVI BioPharma's Drug Candidate AVI-5038 Receives European Orphan Drug Designation For Duchenne Muscular Dystrohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040716&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ophidia%20Products,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040716&THISHREF=http://c.moreover.com/click/here.pl%3fz2538850339%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040716&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ophidia%20Products,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040716&THISHREF=http://c.moreover.com/click/here.pl%3fz2538850339%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCafepharma: Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039967&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ophidia%20Products,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039967&THISHREF=http://c.moreover.com/click/here.pl%3fz2538502958%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039967&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ophidia%20Products,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039967&THISHREF=http://c.moreover.com/click/here.pl%3fz2538502958%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: SOHM India Signs Marketing Agreement Adding 75 Branded Generic Pharmaceutical Products for Distribution Acrosshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039872&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ophidia%20Products,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039872&THISHREF=http://c.moreover.com/click/here.pl%3fz2538445372%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039872&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ophidia%20Products,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039872&THISHREF=http://c.moreover.com/click/here.pl%3fz2538445372%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceuticalProcessing: Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039343&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ophidia%20Products,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039343&THISHREF=http://c.moreover.com/click/here.pl%3fz2538043785%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039343&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ophidia%20Products,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039343&THISHREF=http://c.moreover.com/click/here.pl%3fz2538043785%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPuget Sound Business Journal: Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038844&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ophidia%20Products,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038844&THISHREF=http://c.moreover.com/click/here.pl%3fz2537798153%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038844&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ophidia%20Products,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038844&THISHREF=http://c.moreover.com/click/here.pl%3fz2537798153%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRed Orbit: Transcept Pharmaceuticals Granted First U.S. Patent Covering Intermezzo(R) Formulationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038838&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ophidia%20Products,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038838&THISHREF=http://c.moreover.com/click/here.pl%3fz2537796061%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038838&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ophidia%20Products,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038838&THISHREF=http://c.moreover.com/click/here.pl%3fz2537796061%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRed Orbit: Repros Submits Response To FDA Regarding Androxal(R) Indication For Treatment Of Hypogonadal Men Wishing To Prhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040363&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ophidia%20Products,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040363&THISHREF=http://c.moreover.com/click/here.pl%3fz2538710004%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040363&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ophidia%20Products,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040363&THISHREF=http://c.moreover.com/click/here.pl%3fz2538710004%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: US pharma cos sue Lupin for patent infringementhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039676&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ophidia%20Products,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039676&THISHREF=http://c.moreover.com/click/here.pl%3fz2538316662%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039676&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ophidia%20Products,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039676&THISHREF=http://c.moreover.com/click/here.pl%3fz2538316662%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! India: LearnSomething Brings Phil Keough On Board to Spearhead Retail Products and Serviceshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039556&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ophidia%20Products,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039556&THISHREF=http://c.moreover.com/click/here.pl%3fz2538214254%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039556&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ophidia%20Products,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039556&THISHREF=http://c.moreover.com/click/here.pl%3fz2538214254%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Biogen Beats & Guides Higherhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039526&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ophidia%20Products,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039526&THISHREF=http://c.moreover.com/click/here.pl%3fz2538186921%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039526&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ophidia%20Products,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039526&THISHREF=http://c.moreover.com/click/here.pl%3fz2538186921%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZacks.com: Focus Ahead Consulting to Represent Integrated Genomics' Products and Services in Europehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038932&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ophidia%20Products,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038932&THISHREF=http://c.moreover.com/click/here.pl%3fz2537839675%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038932&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ophidia%20Products,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038932&THISHREF=http://c.moreover.com/click/here.pl%3fz2537839675%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCentre Daily Times: